Pausing methotrexate improves immunogenicity of COVID-19 vaccination in patients with rheumatic diseases
View ORCID ProfileAN Arumahandi de Silva, View ORCID ProfileLM Frommert, View ORCID ProfileFN Albach, View ORCID ProfileJ Klotsche, View ORCID ProfileV Scholz, View ORCID ProfileLM Jeworowski, View ORCID ProfileT Schwarz, View ORCID ProfileA ten Hagen, View ORCID ProfileJ Zernicke, View ORCID ProfileVM Corman, View ORCID ProfileC Drosten, View ORCID ProfileGR Burmester, View ORCID ProfileR Biesen
doi: https://doi.org/10.1101/2021.11.17.21266441
AN Arumahandi de Silva
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
LM Frommert
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
FN Albach
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
J Klotsche
2German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Berlin, Germany
V Scholz
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
LM Jeworowski
3Institute of Virology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany
T Schwarz
3Institute of Virology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany
A ten Hagen
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
J Zernicke
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
VM Corman
3Institute of Virology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany
4Labor Berlin, Charité - Vivantes GmbH, Berlin, Germany
C Drosten
3Institute of Virology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany
GR Burmester
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
R Biesen
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Data Availability
Data are available on reasonable request. All data relevant to the study are included in the article or uploaded as online supplemental information.
Posted November 23, 2021.
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in patients with rheumatic diseases
AN Arumahandi de Silva, LM Frommert, FN Albach, J Klotsche, V Scholz, LM Jeworowski, T Schwarz, A ten Hagen, J Zernicke, VM Corman, C Drosten, GR Burmester, R Biesen
medRxiv 2021.11.17.21266441; doi: https://doi.org/10.1101/2021.11.17.21266441
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in patients with rheumatic diseases
AN Arumahandi de Silva, LM Frommert, FN Albach, J Klotsche, V Scholz, LM Jeworowski, T Schwarz, A ten Hagen, J Zernicke, VM Corman, C Drosten, GR Burmester, R Biesen
medRxiv 2021.11.17.21266441; doi: https://doi.org/10.1101/2021.11.17.21266441
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12562)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (463)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6783)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)